Evidence map›Paper›PMID 37992117›Full record

ArticleThe Journal of infectious diseases2024

Malaria Species Positivity Rates Among Symptomatic Individuals Across Regions of Differing Transmission Intensities in Mainland Tanzania.

Zachary R Popkin-Hall, Misago D Seth, Rashid A Madebe, Rule Budodo, Catherine Bakari, Filbert Francis, Dativa Pereus, David J Giesbrecht, Celine I Mandara, Daniel Mbwambo and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genetic metrics decodeFrontiers in genetics · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Seasonal variation and interspecies dynamics amongmedRxiv : the preprint server for health sciences · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Seroprevalence of antibodies toFrontiers in immunology · 2025
    Article
  18. Article
  19. Application of a new highly multiplexed amplicon sequencing tool to evaluatemedRxiv : the preprint server for health sciences · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Zachary R Popkin-HallInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-8308-5294
Misago D SethNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0002-6743-4108
Rashid A MadebeNational Institute for Medical Research, Dar es Salaam, Tanzania.
Rule BudodoNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0003-0297-9219
Catherine BakariNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0002-8710-1765
Filbert FrancisNational Institute for Medical Research, Tanga Center, Tanga, Tanzania.ORCID 0000-0003-1000-4729
Dativa PereusNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0003-2813-1312
David J GiesbrechtDepartment of Entomology, The Connecticut Agricultural Experiment Station, New Haven, Connecticut, USA.ORCID 0000-0003-2498-4705
Celine I MandaraNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0003-4317-4425
Daniel MbwamboNational Malaria Control Programme, Dodoma, Tanzania.
Sijenunu AaronNational Malaria Control Programme, Dodoma, Tanzania.
Abdallah LusasiNational Malaria Control Programme, Dodoma, Tanzania.
Samwel LazaroNational Malaria Control Programme, Dodoma, Tanzania.
Jeffrey A BaileyDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.ORCID 0000-0002-6899-8204
Jonathan J JulianoInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-0591-0850
Deus S IshengomaNational Institute for Medical Research, Dar es Salaam, Tanzania.ORCID 0000-0003-2040-3416
National Institute for Medical Research · TZAfrican Malaria Network Trust · TZUniversity of North Carolina at Chapel Hill · USBrown University · USConnecticut Agricultural Experiment Station · USHarvard University · US

Funding

Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
NIAID NIH HHS K24 AI134990NIH HHS K24AI134990
6 · The paper itself

Abstract

backgroundRecent data indicate that non-Plasmodium falciparum species may be more prevalent than thought in sub-Saharan Africa. Although Plasmodium malariae, Plasmodium ovale spp., and Plasmodium vivax are less severe than P. falciparum, treatment and control are more challenging, and their geographic distributions are not well characterized.

methodsWe randomly selected 3284 of 12 845 samples collected from cross-sectional surveys in 100 health facilities across 10 regions of Mainland Tanzania and performed quantitative real-time PCR to determine presence and parasitemia of each malaria species.

resultsP. falciparum was most prevalent, but P. malariae and P. ovale were found in all but 1 region, with high levels (>5%) of P. ovale in 7 regions. The highest P. malariae positivity rate was 4.5% in Mara and 8 regions had positivity rates ≥1%. We only detected 3 P. vivax infections, all in Kilimanjaro. While most nonfalciparum malaria-positive samples were coinfected with P. falciparum, 23.6% (n = 13 of 55) of P. malariae and 14.7% (n = 24 of 163) of P. ovale spp. were monoinfections.

conclusionsP. falciparum remains by far the largest threat, but our data indicate that malaria elimination efforts in Tanzania will require increased surveillance and improved understanding of the biology of nonfalciparum species.

Indexed as

MalariaMalaria, FalciparumCross-Sectional StudiesHumansPlasmodium malariaeTanzaniamalarianonfalciparum speciesPlasmodium falciparumPlasmodium malariaePlasmodium ovalePlasmodium vivaxTanzania

Identifiers

PMID37992117
PMCPMC11011190
OpenAlexW4388892713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.